Weight Loss/Diabetes Drug Has Positive Treatment Effect on MASH

Source link :

MILAN — The weight loss and diabetes drug tirzepatide resolved metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, according to the results of the SYNERGY-NASH phase II study. Among 190 participants with biopsy-confirmed MASH and fibrosis, the treatment regimen estimand showed resolution of MASH without worsening of fibrosis in 44% of patients in the once-weekly 5-mg […]

Author : News Health

Publish date : 2024-06-08 23:30:44

Copyright for syndicated content belongs to the linked Source.